Busulfan/cyclophosphamide

Busulfan/cyclophosphamide Reactions 1680, p74 - 2 Dec 2017 Hepatitis B reactivation syndrome: case report A 45-year-old woman developed hepatitis B reactivation syndrome following treatment with busulfan and cyclophosphamide [dosages, routes and time to reaction onset not stated]. The woman was diagnosed with Durie-Salmon Stage II International Staging System II multiple myeloma, in June 1998. She received an allograft transplant in December 1998. Subsequently, she received conditioning therapy with busulfan, cyclophosphamide and total bone marrow irradiation. Post-transplant and the busulfan and cyclophosphamide immunosuppressant therapy, she developed hepatitis B reactivation syndrome. The woman was treated successfully with lamivudine. She developed recurrent extra-medullary plasmacytomas in the breast and right atrium of the heart 11 years and 13 years after the allograft transplant, respectively. Author comment: "The posttransplant course was rather uneventful except for a hepatitis B reactivation syndrome (after immunosuppressant therapy) successfully treated with lamivudine." Stawis AN, et al. Recurrent plasmacytomas after allografting in a patient with multiple myeloma. Case Reports in Medicine 2012: 2012. Available from: URL: http://doi.org/10.1155/2012/168785 - USA 803284649 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Busulfan/cyclophosphamide

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/busulfan-cyclophosphamide-DBn6n8s5BO
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39005-y
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial